The minimal important difference in orthodontic treatment duration: a survey across adult patients

四分位间距 医学 逻辑回归 持续时间(音乐) 还原(数学) 牙科 外科 内科学 几何学 数学 文学类 艺术
作者
Samer Mheissen,Despina Koletsi,Aya Bassam Joria,Haris Khan,Fahad Alharbi,Vasiliki Koretsi,Zubair Hassan Awaisi,Rehan Qamar,Hassan I. Saeed,Yaser Ali Alrefaiy,Theodore Eliades,Pierre Guy
出处
期刊:European Journal of Orthodontics [Oxford University Press]
卷期号:46 (3) 被引量:1
标识
DOI:10.1093/ejo/cjae027
摘要

Abstract Background The minimal important difference (MID) is defined as the smallest difference that the patient perceives as important. Furthermore, the smallest worthwhile effect (SWE) is the important change measured with the benefit-harm trade-off method. The aim of this study was to evaluate the MID in orthodontic treatment duration to inform the decision regarding seeking procedures to accelerate orthodontic tooth movement and reduce treatment duration. Methods We constructed a survey eliciting views of the MID from adult participants from four countries undergoing orthodontic treatment. Ten questions addressed reduction in the treatment duration for both durations 12 and 24 months, and four questions were related to the reduction in treatment duration that the patients would require to undergo surgical or non-surgical adjunctive procedures. We applied a univariable random effects logistic regression model to examine the association between the participants’ characteristics and the MID. Then, we fitted a multivariable logistic random effects regression including significant predictors. Results Four hundred and fifty adults, with a median age of 21 (interquartile range: 19–24), undergoing orthodontic treatment participated in the survey. Of the respondents, 60% considered 15 days as a trivial reduction from 12 months duration of therapy and 70% considered 15 days a trivial reduction from 24 months. Of the respondents, 48% considered the period of 2 months a moderate reduction from 12 months, and 60% considered 2 months a moderate reduction from 24 months. From these results, we inferred that patients considered reductions of approximately 1 month as the MID in the treatment duration for both 12 and 24 months. However, SWE was considerably more than the MID for most of the participants to decide undergoing surgical adjunctive procedures to reduce the time of therapy. The participants required smaller SWE to undergo non-surgical procedures compared to surgical procedures. Conclusion The MID in the treatment duration is one month for both treatment durations 12 and 24 months. Patients require a greater SWE than the MID to undergo adjunctive procedures to shorten the duration, particularly for surgical procedures.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
耍酷寻双完成签到 ,获得积分0
刚刚
感动冰枫发布了新的文献求助10
刚刚
香蕉觅云应助猪头采纳,获得10
1秒前
2233完成签到 ,获得积分10
1秒前
大魁完成签到,获得积分10
1秒前
1秒前
ing完成签到,获得积分10
2秒前
KEQIN发布了新的文献求助30
2秒前
qq完成签到,获得积分10
2秒前
乐观的枕头完成签到,获得积分10
2秒前
卢西完成签到,获得积分10
2秒前
3秒前
哥叔华完成签到,获得积分10
3秒前
乔木木完成签到,获得积分10
3秒前
彭于晏应助苦瓜大王采纳,获得10
3秒前
StarXG完成签到,获得积分10
4秒前
4秒前
夏雪儿完成签到,获得积分10
4秒前
5秒前
正直的青发布了新的文献求助20
5秒前
6秒前
mayunrou3759完成签到 ,获得积分10
7秒前
clock完成签到 ,获得积分10
7秒前
平淡1997亮眼小虫虫完成签到 ,获得积分10
7秒前
大气成仁完成签到,获得积分10
8秒前
123完成签到,获得积分10
8秒前
FashionBoy应助东风渡采纳,获得10
8秒前
驿路梨花完成签到,获得积分10
9秒前
粗暴的傲松完成签到 ,获得积分10
9秒前
9秒前
李佳完成签到,获得积分10
10秒前
竺水儿完成签到,获得积分10
10秒前
晨昏蒙影完成签到 ,获得积分10
10秒前
binglangcha发布了新的文献求助10
10秒前
小随完成签到,获得积分10
11秒前
dh完成签到,获得积分0
11秒前
雪晴完成签到,获得积分10
11秒前
ffff完成签到,获得积分10
11秒前
啦啦啦啦啦啦完成签到,获得积分10
11秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Prompt Engineering for Clinicians: Harnessing AI in Everyday Medical Practice 600
University Physics for the Life Sciences 500
REAL-WORLD EFFICACY AND GENOMIC LANDSCAPE OF POLATUZUMA VEDOTIN-BASED FIRST-LINE THERAPY IN DIFFUSE LARGE B-CELL LYMPHOMA: A FOCUS ON TP53 MUTATIONS AND TREATMENT RESPONSE 500
Handbook of Luminescence Dating 500
Safety Pharmacology 500
《KNN基无铅压电陶瓷电学性能优化与物理机理研究》 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 计算机科学 化学工程 生物化学 物理 内科学 复合材料 催化作用 光电子学 物理化学 电极 细胞生物学 基因 遗传学
热门帖子
关注 科研通微信公众号,转发送积分 6951482
求助须知:如何正确求助?哪些是违规求助? 8635612
关于积分的说明 18310753
捐赠科研通 6393827
什么是DOI,文献DOI怎么找? 3082063
关于科研通互助平台的介绍 2127231
邀请新用户注册赠送积分活动 2058938